A. Garcia - AI Profile | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P385: detection of kmt2a partial tandem duplications in acute myeloid leukemia patients by ngs

A. Artigas-Baleri, G. Oñate, A. Brell, J. Esteve, S. Vives, M. Tormo, M. Arnan,A. Garcia, R. Coll, A. Sampol, J. Bargay, F. Vall-llovera,

HemaSphere (2022): 285-286

引用0浏览0引用

Lymphocyte dose in graft, clonogenic efficiency and male sex as predictive factors of early lymphocyte recovery following autologous stem cell transplantation

J. Fernandez-Sojo,J. Cid, C. Azqueta, E. Valdivia, L. Martorell, M. Codinach, J. Marsal,A. Mussetti, A. Esquirol, M. Trabazo, I. Benitez, C. Ferra,

BONE MARROW TRANSPLANTATIONno. SUPPL 1 (2022)

引用0浏览0引用

P565: improved outcome of patiens with acute myeloid leukemia harboring flt3 mutation in the era of targeted therapy

G. Oñate, M. Pratcorona,A. Garrido, A. Artigas,A. Bataller, M. Tormo, M. Arnan, S. Vives,R. Coll,O. Salamero, F. Vall-Llovera, A. Sampol,

HemaSphere (2022): 464-465

引用0浏览0引用

Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

M. Cabezón,R. Malinverni, J. Bargay,B. Xicoy, S. Marcé,A. Garrido, M. Tormo,L. Arenillas,R. Coll, J. Borras,M. J. Jiménez, M. Hoyos,

CLINICAL EPIGENETICS（2021）

引用15浏览0WOS引用

Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)

E. Bussaglia, M. Pratcorona, M. Carricondo, L. Sansegundo,M. A. Rubio, A. Monter, A. Brell,I. Badell,J. Esteve, M. Arnan, C. Talarn, M. Tormo,

Ann Hematol（2020）

引用4浏览0WOS引用

THE UGT1A1 GENOTYPE INFLUENCES THE SURVIVAL OF PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA OF INTERMEDIATE CITOGENETIC RISK

J. Diaz Santa, R. Rodriguez Romanos, G. Osca Gelis,R. Coll Jorda,M. Pratcorona, C. Moret Puig,L. Escoda, I Heras, M. Arnan,S. Vives,O. Salamero, N. Lloveras Guelquee,

HAEMATOLOGICA（2019）

引用0浏览0引用

ANALYSIS OF THE INFLUENCE OF DNMT3A ON MEASURABLE RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA WITH MUTATION OF NPM1

G. Onate,A. Bataller,A. Garrido,J. Esteve, M. Arnan,S. Vives,R. Coll,J. Bargay,O. Salamero,L. Escoda,A. Garcia, M. P. Queipo de Llano,

HAEMATOLOGICA（2019）

引用0浏览0引用

TP53 Mutations in High Risk Myelodysplastic Syndromes Patients Treated with Azacitidine According to Cetlam Group Protocol

M. Cabezón,Joan Bargay,Blanca Xicoy,Olga García,M. Tormo,Laura Palomo,S. Marcé,David Valcárcel,Carmen Pedro,María-José Jiménez, J.B. Borras,Ramon Guardia,

LEUKEMIA RESEARCH（2017）

引用0浏览0引用

ACUTE MYELOID LEUKEMIA WITH INTERMEDIATE-RISK CYTOGENETICS AND A FAVORABLE GENOTYPE: PROGNOSTIC FACTORS AND RESULTS IN PATIENTS TREATED ACCORDING THE SPANISH CETLAM PROTOCOLS

J. Sierra,A. Garrido,M. Diaz-Beya,S. Vives,H. Pomares,R. Guardia,M. Cervera,M. Queipo de Llano,O. Salamero,A. Garcia,J. Marti-Tutusaus,C. Pedro,

HAEMATOLOGICA（2017）

引用0浏览0引用

FINAL RESULTS OF THE CETLAM LAM-2003 TRIAL FOR THE TREATMENT OF PRIMARY AML UP TO THE AGE OF 70

A. Garrido, S. Brunet, M. Calabuig,M. Diaz-Beya,S. Vives,M. Cervera,H. Pomares,R. Guardia,O. Salamero,M. Queipo de Llano,J. Bargay, A. Sampol,

HAEMATOLOGICA（2017）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn